Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

78 results about "Patient feedback" patented technology

Device and method for automatically regulating supplemental oxygen flow-rate

InactiveUS20060225737A1Minimize biasPrevent adverse eventsRespiratorsElectrocardiographySupplemental oxygen therapyClosed loop
Device and method for limiting adverse events during supplemental oxygen therapy are disclosed. In the present invention, the oxygen flow between a patient and an oxygen source is controlled with a valve such as a proportional solenoid capable of constraining flow-rates within a continuous range. The flow-rate of oxygen is accurately controlled in a closed-loop with flow-rate measurements. Measures of a patient's vital physiological statistics are used to automatically determine optimum therapeutic oxygen flow-rate. Controller signal filtering is disclosed to improve the overall response and stability. The control algorithm varies flow-rates to minimize disturbances in the patient feedback measurements.
Owner:IOBBI MR MARIO

System and method for stimulus calibration for an implantable pulse generator

A system, method, and computer program product for calibrating a stimulation device such as an implantable pulse generator (IPG). An IPG, whether it is a self-contained implantable pulse generator (SCIPG) or externally-powered implantable pulse generator (EPIPG), communicates with an external programmer to determine the characteristics of the stimuli delivered to the lead electrodes. An external programmer is used with patient feedback to determine initial threshold levels, and using the initial threshold levels, to determine threshold levels for combined electrode arrays.
Owner:ADVANCED NEUROMODULATION SYST INC

Auto adjusting system for brain tissue stimulator

An implantable neurostimulator for treating disorders such as epilepsy, pain, movement disorders and depression includes a detection subsystem capable of detecting a physiological condition and a therapy subsystem capable of providing a course of therapy in response to the condition. The therapy subsystem includes an auto-adjust module for automatically adjusting one or more parameters of the therapy so that the therapy subsystem can provide an adjusted parameter to the patient and solicit the patient's feedback concerning the adjustment without requiring the presence of, or immediate involvement with, a clinician or physician. The patient feedback can be analyzed by computer, clinician or a combination of both to determine an optimal range of parameters for subsequent courses of therapy. In this manner, information useful in tuning the neurostimulator therapy parameters to optimize them for individual patient can be acquired automatically outside of the traditional clinical setting, saving time and minimizing patient fatigue that otherwise would be experience in marathon, in-clinic tuning sessions. The auto-adjust module also can be configured to prompt the patient to provide feedback even when parameters are not being adjusted, so as to acquire information for a baseline or about any placebo effect when the patient is otherwise expecting changes to the therapy to be made.
Owner:NEUROPACE

Auto adjusting system for brain tissue stimulator

An implantable neurostimulator for treating disorders such as epilepsy, pain, movement disorders and depression includes a detection subsystem capable of detecting a physiological condition and a therapy subsystem capable of providing a course of therapy in response to the condition. The therapy subsystem includes an auto-adjust module for automatically adjusting one or more parameters of the therapy so that the therapy subsystem can provide an adjusted parameter to the patient and solicit the patient's feedback concerning the adjustment without requiring the presence of, or immediate involvement with, a clinician or physician. The patient feedback can be analyzed by computer, clinician or a combination of both to determine an optimal range of parameters for subsequent courses of therapy. In this manner, information useful in tuning the neurostimulator therapy parameters to optimize them for individual patient can be acquired automatically outside of the traditional clinical setting, saving time and minimizing patient fatigue that otherwise would be experience in marathon, in-clinic tuning sessions. The auto-adjust module also can be configured to prompt the patient to provide feedback even when parameters are not being adjusted, so as to acquire information for a baseline or about any placebo effect when the patient is otherwise expecting changes to the therapy to be made.
Owner:NEUROPACE

Diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system

InactiveCN103565521AReal-time monitoring of daily lifeMonitor daily lifeDiagnosticsSurgeryDisease monitoringData information
The invention provides a diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system. The diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system comprises a front-end monitoring system, an information middleware, an expert system and a center application system. The front-end monitoring system is connected with the center application system sequentially through the information middleware and the expert system, the front-end monitoring system sends data information to the information middleware and stores the data information into a database, the information middleware sends the data information to the expert system, and the expert system sends conclusions of the physical condition to the center application system. The diabetes and cardiovascular and cerebrovascular disease monitoring and treatment system can utilize low power consumption wireless communication technologies and sensing technologies to timely monitor physiological parameters, daily life, diet, exercise and medicine-taking time of a patient. A doctor can give patients feedbacks and advice by analyzing monitored data of the patients with chronic diseases and control the development of the diseases by supervising the implementation of the advice so as to improve the condition of the patients.
Owner:DIGICAN SHANGHAI CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products